Literature DB >> 21719891

Gout and hyperuricaemia in adults with cystic fibrosis.

Alex Horsley1, Jennifer Helm, Amanda Brennan, Rowland Bright-Thomas, Kevin Webb, Andrew Jones.   

Abstract

Gout has not been described previously as a complication in cystic fibrosis (CF). Here we present data on nine CF patients who have presented with symptoms of acute gout. This gives an estimated prevalence of gout of around 2.5% in our adult CF population, compared to a previously described prevalence in the non-CF population of just over 1%. Serum urate is measured routinely at the annual review in our unit. Mean (SD) serum urate was 0.40 (0.09) mmol/L in male CF patients (n = 108) and 0.31 (0.08) mmol/L in female patients (n = 74). This was significantly greater than in historical controls. Thirty-seven percent of male CF patients and 36% of female patients had serum urate levels above the upper limit of normal.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719891      PMCID: PMC3128168          DOI: 10.1258/jrsm.2011.s11106

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  12 in total

Review 1.  Diagnosis and management of gout.

Authors:  Martin Underwood
Journal:  BMJ       Date:  2006-06-03

2.  Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.

Authors:  F B Stapleton; J Kennedy; S Nousia-Arvanitakis; M A Linshaw
Journal:  N Engl J Med       Date:  1976-07-29       Impact factor: 91.245

3.  Iatrogenic hyperuricemia in children with cystic fibrosis.

Authors:  G P Davidson; F M Hassel; D Crozier; M Corey; G G Forstner
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

4.  The arthropathy of cystic fibrosis.

Authors:  J Dixey; A N Redington; R C Butler; M J Smith; J R Batchelor; D F Woodrow; M E Hodson; J C Batten; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

5.  Gout is on the increase in New Zealand.

Authors:  P Klemp; S A Stansfield; B Castle; M C Robertson
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

6.  Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; H R Schumacher; K G Saag
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey.

Authors:  Jee Woong J Choi; Earl S Ford; Xiang Gao; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2008-01-15

8.  Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.

Authors:  S Nouisa-Arvanitakis; F B Stapleton; M A Linshaw; J Kennedy
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

Review 9.  The musculoskeletal manifestations of cystic fibrosis.

Authors:  P J Rush; A Shore; C Coblentz; D Wilmot; M Corey; H Levison
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532

10.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

View more
  2 in total

1.  Uric acid and thiocyanate as competing substrates of lactoperoxidase.

Authors:  Antonia Seidel; Heather Parker; Rufus Turner; Nina Dickerhof; Irada S Khalilova; Sigurd M Wilbanks; Anthony J Kettle; Guy N L Jameson
Journal:  J Biol Chem       Date:  2014-06-13       Impact factor: 5.157

2.  Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.

Authors:  Edward H Abraham; Guido Guidotti; Eliezer Rapaport; David Bower; Jack Brown; Robert J Griffin; Andrew Donnelly; Ellen D Waitzkin; Kenon Qamar; Mark A Thompson; Sukumar Ethirajan; Kent Robinson
Journal:  Purinergic Signal       Date:  2021-05-10       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.